Finally, and most importantly, miR-181b inhibition decreases atherosclerotic plaque formation in mouse models, primarily through upregulation of macrophage TIMP-3 expression, whereas in aneurysm models there is an additional effect on elastin production from VSMC that is supported by in vitro studies. The gene discussed is ELN; the disease is aneurysm.